Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
14.63
+0.58 (4.13%)
May 14, 2025, 10:18 AM - Market open
Company Description
Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States.
It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans.
The company was founded in 2013 and is based in Orange, California.
Alignment Healthcare, Inc.
| Country | United States |
| Founded | 2013 |
| IPO Date | Mar 26, 2021 |
| Industry | Healthcare Plans |
| Sector | Healthcare |
| Employees | 1,679 |
| CEO | John Kao |
Contact Details
Address: 1100 West Town and Country Road, Suite 1600 Orange, California 92868 United States | |
| Phone | 844 310 2247 |
| Website | alignmenthealth.com |
Stock Details
| Ticker Symbol | ALHC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $18.00 |
| CIK Code | 0001832466 |
| CUSIP Number | 01625V104 |
| ISIN Number | US01625V1044 |
| Employer ID | 46-5596242 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| John E. Kao | Founder, Chief Executive Officer and Director |
| Dawn Christine Maroney | President |
| Andreas Wagner | Chief Human Resources Officer |
| Dr. Hyong J. Kim M.D. | Chief Medical Officer |
| Dr. Donald S. Furman M.B.A., M.D. | Co-Founder and Chief Clinical Officer |
| James M. Head | Chief Financial Officer |
| Robert L. Scavo | Chief Information Officer |
| Christopher J. Joyce J.D. | Chief Legal and Administrative Officer |
| Sergio Zaldivar | Senior Vice President of Business Operations |
| Kerry Matsumoto | Senior Vice President of Clinical Product |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 12, 2025 | SCHEDULE 13G/A | Filing |
| May 1, 2025 | 144 | Filing |
| May 1, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Apr 25, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 15, 2025 | 8-K | Current Report |
| Apr 14, 2025 | 144 | Filing |
| Apr 14, 2025 | 144 | Filing |